glp-1 weight loss patches Do Work? Singapore authorities looking into illegal
Description
Tirzepatide Introduced in 2022 under the brand name Mounjaro, Tirzepatide is a medication that combines the effects of GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 receptor agonists
Why Should We Care
Average weight loss Mounjaro and Wegovy both have proven effectiveness at aiding weight loss in clinical trials
Dopamine promotes cognitive effort by biasing the benefits versus costs of cognitive work
The list continues to grow
Indicators of high risk include being 55 years of age or older with coronary, carotid, or lower extremity artery stenosis of more than 50% or with left ventricular hypertrophy
